BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ACKC, ACTION TO CURE KIDNEY CANCER — Receipts Report

LD-2 disclosure · 4th Quarter - Termination (No Activity)

ACKC, ACTION TO CURE KIDNEY CANCER

via VERITAS, LLC

4th Quarter (Oct 1 - Dec 31) · 2017Posted Dec 2, 2017Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: ACKC, ACTION TO CURE KIDNEY CANCER
Description: Kidney cancer education and awareness
Location: New York · United States of America

Registrant

Firm: VERITAS, LLC
Description: Advocacy for medical research funding
Location: Philadelphia, Pennsylvania, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.